Cadrenal Therapeutics, Inc
Fundamentals
Oldest to newest| Line | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating income | −$2.7M | −$7.6M | −$11.0M | −$13.5M |
| Net income | −$6.7M | −$8.4M | −$10.7M | −$13.2M |
| Operating cash flow | −$1.2M | −$3.5M | −$7.4M | −$12.6M |
| Free cash flow | −$1.2M | −$3.5M | −$7.4M | −$12.6M |
| Cash | $32,586 | $8.4M | $10.0M | $4.0M |
| Debt | $597,068 | none on file | none on file | none on file |
| Shares outstanding | 8.2M | 868.2K | 1.8M | 2.3M |